สมัครสมาชิก

เข้าสู่ระบบ

Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia

License Transfer from Solasia to Lee’s Pharm for the Sales Promotion of Sancuso® and episil® in three cities in China

ดาวน์โหลดข่าวฉบับเต็ม (PDF)

ที่มา: Lee’s Pharmaceutical Holdings – News & Media

ข่าวสารอื่นๆ

Lee’s Pharm successfully held The 8th Pulmonary Arterial Hypertension Summit

พฤษภาคม 23, 2023
Lee’s Pharm successfully held The 8th Pulmonary Arterial Hypertension Summit

Launching of Lee’s Pharm Flagship Store on Ali’s and Jingdong’s e-commerce platforms in China

เมษายน 5, 2022
Launching of Lee’s Pharm Flagship Store on Ali’s and Jingdong’s e-commerce platforms in China

Dr. LI Xiaoyi, Founder of Lee’s Pharm, attended the “Thematic Seminar on Biotechnology Innovation and Translation Project”

มีนาคม 5, 2025
Dr. LI Xiaoyi, Founder of Lee’s Pharm, attended the “Thematic Seminar on Biotechnology Innovation and Translation Project”

Lee’s flagship product Ferplex® was elected as “2022 Most Valuable Product in Partnership for Drug Store Chain in China”

กรกฎาคม 16, 2022
Lee’s flagship product Ferplex® was elected as “2022 Most Valuable Product in Partnership for Drug Store Chain in China”

New product Natulan® obtained Drug Registration Certificate

พฤษภาคม 20, 2022
New product Natulan® obtained Drug Registration Certificate

Zhaoke-Hefei was recognized as “2022 Excellent Enterprise of National Intellectual Property” by the China National Intellectual Property Administration

ตุลาคม 17, 2022
Zhaoke-Hefei was recognized as “2022 Excellent Enterprise of National Intellectual Property” by the China National Intellectual Property Administration
thThai
en_USEnglish thThai